0001161697-24-000062.txt : 20240206
0001161697-24-000062.hdr.sgml : 20240206
20240206170022
ACCESSION NUMBER: 0001161697-24-000062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240205
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DENKHAUS DONALD A
CENTRAL INDEX KEY: 0001278439
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 24601043
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1500
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 02-05-2024
X0508
4
2024-02-05
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001278439
DENKHAUS DONALD A
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
1
0
0
0
0
Common Stock, par value $0.001 per share
2024-02-05
4
M
0
40000
4.01
A
434333
D
Options to purchase common stock
4.01
2024-02-05
4
M
0
40000
0
D
2025-01-02
Common Stock
40000
192931
D
Derivative securities vested in three equal tranches on January 2, 2019, 2020 and 2021.
/s/ Donald A. Denkhaus
2024-02-06